Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Einhorn

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Medgenmed : Medscape General Medicine|January 14, 2005
Advances in diabetes for the millennium: insulin treatment and glucose monitoringDaniel Einhorn
Journal of Diabetes|November 21, 2019
Treatment of glycemic control in diabetes in the CVOT eraDaniel Einhorn
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 20, 2016
REVISITING THE USE OF PIOGLITAZONE IN THE TREATMENT OF TYPE 2 DIABETESDaniel Einhorn, Vivian Fonseca
Journal of Diabetes|October 27, 2021
Fatty kidney disease: The importance of ectopic fat deposition and the potential value of imagingChristian Mende, Daniel Einhorn
Frontiers in Endocrinology|June 5, 2012
Hypoglycemia in type 2 diabetes: current controversies and changing practicesZachary T Bloomgarden, Daniel Einhorn
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 12, 2010
Hemoglobin A1c in diabetes diagnosis: time for cautionZachary T Bloomgarden, Daniel Einhorn
Journal of Diabetes|September 23, 2014
Advances in sleep researchDaniel Einhorn, Zachary T Bloomgarden
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 29, 2015
COMBINING CREATININE-BASED eGFR WITH CYSTATIN C-BASED EGFR TO BETTER ASSESS RENAL FUNCTION IN PATIENTS WITH DIABETES AND CHRONIC KIDNEY DISEASE 3A: IMPLICATIONS FOR DRUG SELECTION AND DOSAGE IN TYPE 2 DIABETESDaniel Einhorn, Christian W Mende
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 24, 2019
FATTY KIDNEY DISEASE: A NEW RENAL AND ENDOCRINE CLINICAL ENTITY? DESCRIBING THE ROLE OF THE KIDNEY IN OBESITY, METABOLIC SYNDROME, AND TYPE 2 DIABETESChristian W Mende, Daniel Einhorn
Journal of Diabetes|September 29, 2011
Comprehensive diabetes cardiovascular treatment = sugar + blood pressure + lipidsZachary Bloomgarden, Yehuda Handelsman, Daniel Einhorn
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Medgenmed : Medscape General Medicine|January 14, 2005
Advances in diabetes for the millennium: insulin treatment and glucose monitoringDaniel Einhorn
Journal of Diabetes|November 21, 2019
Treatment of glycemic control in diabetes in the CVOT eraDaniel Einhorn
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 20, 2016
REVISITING THE USE OF PIOGLITAZONE IN THE TREATMENT OF TYPE 2 DIABETESDaniel Einhorn, Vivian Fonseca
Journal of Diabetes|October 27, 2021
Fatty kidney disease: The importance of ectopic fat deposition and the potential value of imagingChristian Mende, Daniel Einhorn
Frontiers in Endocrinology|June 5, 2012
Hypoglycemia in type 2 diabetes: current controversies and changing practicesZachary T Bloomgarden, Daniel Einhorn
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 12, 2010
Hemoglobin A1c in diabetes diagnosis: time for cautionZachary T Bloomgarden, Daniel Einhorn
Journal of Diabetes|September 23, 2014
Advances in sleep researchDaniel Einhorn, Zachary T Bloomgarden
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 29, 2015
COMBINING CREATININE-BASED eGFR WITH CYSTATIN C-BASED EGFR TO BETTER ASSESS RENAL FUNCTION IN PATIENTS WITH DIABETES AND CHRONIC KIDNEY DISEASE 3A: IMPLICATIONS FOR DRUG SELECTION AND DOSAGE IN TYPE 2 DIABETESDaniel Einhorn, Christian W Mende
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 24, 2019
FATTY KIDNEY DISEASE: A NEW RENAL AND ENDOCRINE CLINICAL ENTITY? DESCRIBING THE ROLE OF THE KIDNEY IN OBESITY, METABOLIC SYNDROME, AND TYPE 2 DIABETESChristian W Mende, Daniel Einhorn
Journal of Diabetes|September 29, 2011
Comprehensive diabetes cardiovascular treatment = sugar + blood pressure + lipidsZachary Bloomgarden, Yehuda Handelsman, Daniel Einhorn
Pageof 7